Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Suzhou Qi Biodesign Biotechnology Company Limited is currently managing 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct examiners and 4 distinct art units, indicating a broad and diversified prosecution strategy. This distribution suggests that the company's innovations are being reviewed by multiple specialized groups within the USPTO.
The busiest examiner for the portfolio is KINGDON, CATHY, who is responsible for 1 pending office action. Given that there are 4 pending office actions in total, the workload is spread, with no single examiner handling more than 1 case. This lack of concentration requires the company to manage 4 separate examiner relationships and navigate the specific nuances of 4 different art units simultaneously.
The presence of 4 distinct art units for the 4 pending actions highlights a high degree of technical variety in the company's current filings. Practitioners must adapt their strategies to the diverse expectations of these different units. The data reflects a portfolio that is actively engaged across multiple fronts of the patent examination process under examiners like KINGDON, CATHY.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KINGDON, CATHY | 1 | 80.3% | +2.5% |
| CHATTERJEE, JAYANTA | 1 | 45.5% | +80.0% |
| PRIEST, AARON A | 1 | 61.3% | +25.7% |
| PARISI, JESSICA DANIELLE | 1 | 75.8% | +32.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18689009 | Improved Prime Editing System | KINGDON, CATHY | — |
| 17923264 | DIRECTED EVOLUTION METHOD BASED ON PRIMARY AND SECONDARY REPLICON OF GEMINI VIRUS | PARISI, JESSICA DANIELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909309 | MULTIPLEX GENOME EDITING METHOD AND SYSTEM | CHATTERJEE, JAYANTA | 72d overdue |
| 17909308 | METHOD FOR DETECTING RANDOM OFF-TARGET EFFECT OF SINGLE-BASE EDITING SYSTEM | PRIEST, AARON A | — |
| 17923264 | DIRECTED EVOLUTION METHOD BASED ON PRIMARY AND SECONDARY REPLICON OF GEMINI VIRUS | PARISI, JESSICA DANIELLE | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| 1662 | 1 |
| 1681 | 1 |
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18689009 | Improved Prime Editing System | KINGDON, CATHY | 1663 | §102§103§112 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 17909309 | MULTIPLEX GENOME EDITING METHOD AND SYSTEM | CHATTERJEE, JAYANTA | 1662 | §103 | Final Rejection | 72d overdue | Pending | Sep 21, 2023 |
| 17909308 | METHOD FOR DETECTING RANDOM OFF-TARGET EFFECT OF SINGLE-BASE EDITING SYSTEM | PRIEST, AARON A | 1681 | §112 | Final Rejection | — | Pending | Mar 13, 2023 |
| 17923264 | DIRECTED EVOLUTION METHOD BASED ON PRIMARY AND SECONDARY REPLICON OF GEMINI VIRUS | PARISI, JESSICA DANIELLE | 1684 | §101§102§103§112 | Final Rejection | — | Pending | Nov 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial